Merck Sharp & Dohme B.V.
PolandAll drugs from this manufacturer
-
The vaccine is used to prevent infections caused by pneumococci, which can lead to pneumonia, meningitis, and bloodstream infections. It is intended for children over 2 years of age and adults, especially those in high-risk groups, such as the elderly, individuals with heart, lung, or liver disease, diabetes, immunocompromised individuals, or those without a spleen.
Dosage form: solution for injection
Active substance Dosage streptococcus pneumoniae capsular polysaccharide 25 mcg ATC: J07AL01
-
The medicine is used for the treatment of asthma in children (from 6 months to 5 years of age) to prevent symptoms during the day and at night. It may also be used to prevent exercise-induced bronchoconstriction in children over 2 years of age.
Dosage form: granules
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The vaccine is used to immunize the body against infections caused by hepatitis A virus.
Dosage form: suspension for injection
Active substance Dosage hepatitis a virus, strain cr326f inactivated 25 U ATC: J07BC02
-
The vaccine is used to immunize the body against infections caused by the hepatitis A virus. It is recommended for healthy adults (18 years and older) who are at risk of infection or for whom the disease may be life-threatening (e.g., individuals with HIV or hepatitis C).
Dosage form: suspension for injection
Active substance Dosage hepatitis a virus, strain cr326f inactivated 50 U ATC: J07BC02
-
The vaccine helps protect adults and children against chickenpox. It may also prevent the onset of the disease or mitigate its course (reducing the number of skin lesions and the duration of the illness) in individuals who have recently been exposed to the virus.
Dosage form: powder and solvent for preparation of injection suspension in vial-syringe
Active substance Dosage vaccinia vaccine live not less than 1350 PFU/0.5 ml ATC: J07BK01